One Ascent Wealth Management LLC Ascendis Pharma A/S Transaction History

One Ascent Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$84.03 - $110.23 $169,236 - $222,003	-2,014 Reduced 47.77%	2,202 $227,000
Q2 2022 Aug 08, 2022	SELL	$78.08 - $117.61 $68,163 - $102,673	-873 Reduced 17.15%	4,216 $392,000
Q1 2022 May 12, 2022	BUY	$102.18 - $135.75 $83,072 - $110,364	813 Added 19.01%	5,089 $597,000
Q4 2021 Feb 08, 2022	BUY	$127.1 - $169.66 $1,652 - $2,205	13 Added 0.3%	4,276 $575,000
Q3 2021 Nov 12, 2021	SELL	$112.67 - $176.92 $406,175 - $637,796	-3,605 Reduced 45.82%	4,263 $679,000
Q1 2021 Apr 27, 2021	BUY	$124.92 - $173.33 $247,091 - $342,846	1,978 Added 33.58%	7,868 $1.01 Million
Q4 2020 Feb 08, 2021	BUY	$151.2 - $182.76 $890,567 - $1.08 Million	5,890 New	5,890 $982,000

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of One Ascent Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on One Ascent Wealth Management LLC with notifications on news.